State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Laboratory of Metabolic Regulation and Drug Target Discovery, School of Pharmacy, Jiangsu Province Key Laboratory of Drug Metabolism, China Pharmaceutical University, Nanjing, Jiangsu, China.
Gut Microbes. 2023 Jan-Dec;15(1):2201156. doi: 10.1080/19490976.2023.2201156.
Genetic variants are traditionally known to shape the susceptibility to neuropsychiatric disorders. An increasing number of studies indicate that remodeling of the gut microbiome by genetic variance serves as a versatile regulator of gut-brain crosstalk and behavior. Evidence also emerges that certain behavioral symptoms are specifically attributed to gut microbial remodeling and gut-to-brain signals, which necessitates rethinking of neuropsychiatric disease etiology and treatment from a systems perspective of reciprocal gene-microbe interactions. Here, we present an emerging picture of how gut microbes and host genetics interactively shape complex psychiatric phenotypes. We illustrate the growing understanding of how the gut microbiome is shaped by genetic changes and its connection to behavioral outcome. We also discuss working strategies and open questions in translating associative gene-microbiome-behavior findings into causal links and novel targets for neurobehavioral disorders. Dual targeting of the genetic and microbial factors may expand the space of drug discovery for neuropsychiatric diseases.
遗传变异被传统认为会影响神经精神疾病的易感性。越来越多的研究表明,遗传变异重塑肠道微生物组是肠道-大脑通讯和行为的多功能调节剂。有证据表明,某些行为症状专门归因于肠道微生物重塑和肠道到大脑的信号,这需要从互惠基因-微生物相互作用的系统角度重新思考神经精神疾病的病因和治疗。在这里,我们呈现了一个新兴的图景,说明肠道微生物和宿主遗传如何相互作用塑造复杂的精神表型。我们说明了越来越多的关于遗传变化如何塑造肠道微生物组及其与行为结果的联系的理解。我们还讨论了将关联的基因-微生物-行为发现转化为因果关系和神经行为障碍的新靶点的工作策略和开放性问题。遗传和微生物因素的双重靶向可能会为神经精神疾病的药物发现开辟新的空间。